|
Volumn 89, Issue 2, 2002, Pages 175-181
|
Evidence-based medicine applied to cervical cancer
|
Author keywords
Cervical cancer; Cochrane institute; Evidence based medicine; Randomized controlled trials
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CANCER SCREENING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COCHRANE LIBRARY;
COLPOSCOPY;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
EVIDENCE BASED MEDICINE;
HEALTH CARE ACCESS;
HEALTH CARE INDUSTRY;
HEALTH CARE MANAGEMENT;
HEALTH CARE QUALITY;
HEALTH MAINTENANCE ORGANIZATION;
HUMAN;
META ANALYSIS;
NATIONAL HEALTH SERVICE;
PEER REVIEW;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PUBLICATION;
TREATMENT OUTCOME;
UTERINE CERVIX CARCINOMA;
WART VIRUS;
ADULT;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
INTERNATIONAL COOPERATION;
PEER REVIEW;
RANDOMIZED CONTROLLED TRIALS;
UTERINE CERVICAL NEOPLASMS;
|
EID: 0036849799
PISSN: 01681702
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-1702(02)00186-7 Document Type: Conference Paper |
Times cited : (5)
|
References (5)
|